Smaller biotech companies Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
21:50
Jan 12
Jan 12
Smaller biotechs face long-term funding risk.
Government cuts to U.S. university research funding are not disrupting Acadia today, but she worries about the longer-term knock-on effect, especially for smaller biotechs that rely on academia for initial innovation.
MED
About Smaller biotech companies Investor Commentary
Across the available history and selected sources, Buzzberg tracks Smaller biotech companies across 1 sources: 0 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Catherine Owen Adams.